Contact
Please use this form to send email to PR contact of this press release:
Opinion/decision on a Paediatric investigation plan (PIP): Mekinist,Trametinib (dimethyl sulfoxide), decision type: , therapeutic area: , PIP number: P/0392/2020
TO: